Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A07EC02	PENTASA	B	Mesalazine - 1g	1g	Enema	2,791,161 L.L
J01CR02	POSMOX	G	Amoxicillin (trihydrate) - 875mg, Clavulanic Acid (potassium) - 125mg	1g	Powder	616,824 L.L
N02BE01	PARACETAMOL ARROW	G	Paracetamol - 1g	1g	Tablet	80,631 L.L
N06BA09	PMS-ATOMOXETINE	G	Atomoxetine (HCl) - 18mg	18mg	Capsule	3,744,073 L.L
L03AB11	PEGASYS	BioTech	Peginterferon alfa-2a - 180mcg/0.5ml	180mcg/0.5ml	Injectable solution	18,197,019 L.L
L03AB11	PEGASYS	BioTech	Peginterferon alfa-2a - 180mcg/0.5ml	180mcg/0.5ml	Injectable solution	60,563,068 L.L
L03AB11	PEGASYS	BioTech	Peginterferon alfa-2a - 180mcg/0.5ml	180mcg/0.5ml	Injectable solution	L.L
L03AB11	PEGASYS	BioTech	Peginterferon alfa-2a - 180mcg/0.5ml	180mcg/0.5ml	Injectable solution	L.L
A12CX	PHOSPHATE DIPOTASSIQUE RENAUDIN	G	Phosphate dipotassique - 174.20mg/ml	174.20mg/ml	Injectable solution	1,189,301 L.L
B03AA07	PEDIAFER	G	Ferrous (sulfate) - 15mg/ml	15mg/ml	Drops	550,975 L.L
H02AB06	PEDIACORT	G	Prednisolone sodium phosphate - 15mg/5ml	15mg/5ml	Solution	417,231 L.L
H02AB06	PREDALONE	G	Prednisolone - 15mg/5ml	15mg/5ml	Syrup	890,776 L.L
H02AB06	PREDO	G	Prednisolone sodium phosphate - 15mg/5ml	15mg/5ml	Syrup	1,018,633 L.L
H02AB06	PREDOXONE	G	Prednisolone sodium phosphate - 15mg/5ml	15mg/5ml	Solution	417,231 L.L
A10BG03	PIODIAB 15	G	Pioglitazone HCl - 15mg	15mg	Tablet	1,053,317 L.L
N06AB10	PRAMACYT 15	G	Escitalopram (oxalate) - 15mg	15mg	Tablet, film coated	921,492 L.L
N06AB10	PRYLEX 15	G	Escitalopram (oxalate) - 15mg	15mg	Tablet, film coated	921,492 L.L
N05AX12	PIRIFY	G	Aripiprazole - 15mg	15mg	Tablet	795,555 L.L
B05XA01	POTASSIUM CHLORIDE	G	Potassium chloride - 15g/100ml	15g/100ml	Injectable solution	5,688,441 L.L
L01CD01	PACLITAXEL NEAPOLIS	G	Paclitaxel - 150mg/25ml	150mg/25ml	Injectable concentrate for solution	15,665,972 L.L
L01CD01	PANATAXEL	G	Paclitaxel - 150mg/25ml	150mg/25ml	Injectable concentrated solution	16,521,761 L.L
M01AE03	PROFEMIGR	B	Ketoprofen - 150mg	150mg	Tablet, scored	302,365 L.L
L01EM03	PIQRAY	B	Alpelisib - 150mg	150mg	Tablet, film coated	359,195,954 L.L
L01EM03	PIQRAY	B	Alpelisib - 200mg, Alpelisib - 50mg	150mg	Tablet, film coated	359,195,954 L.L
J02AC01	PANZIMOL	G	Fluconazole - 150mg	150mg	Capsule, hard	428,686 L.L
N02BF02	PLENICA	G	Pregabalin - 150mg	150mg	Capsule	997,131 L.L
N02BF02	PMS-PREGABALIN	G	Pregabalin - 150mg	150mg	Capsule	2,534,487 L.L
N02BF02	PREGAFORTE 150	G	Pregabalin - 150mg	150mg	Capsule	1,023,880 L.L
B01AE07	PRADAXA	B	Dabigatran etexilate (mesilate) - 150mg	150mg	Capsule, hard	3,031,709 L.L
M05BA07	PMS-RISEDRONATE	G	Risedronate sodium - 150mg	150mg	Tablet	806,306 L.L

...